C12N 2710/00052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2710/00052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 8
- Assignees
- 7
- Inventors
- 14
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics25 Nov 2025US 12,480,097 B2Research Institute At Nationwide Children's Hospital
- Method of producing a polypeptide or virus of interest in a continuous cell culture18 Aug 2020US 10,745,672 B2Baxalta Incorporated
- Method of producing a polypeptide or virus of interest in a continuous cell culture5 Mar 2019US 10,221,400 B2Baxalta Incorporated
- Method of producing a polypeptide or virus of interest in a continuous cell culture16 May 2017US 9,650,612 B2Baxalta Incorporated
- Method of producing a polypeptide or virus of interest in a continuous cell culture12 Nov 2013US 8,580,554 B2Baxter Healthcare S. A.
- Compositions and methods for production of recombinant adeno-associated virus13 Apr 2023US 2023/0111672 A1The Regents of the University of California
- Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics19 May 2022US 2022/0154149 A1Research Institute At Nationwide Children's Hospital
- Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity12 Nov 2020US 2020/0354409 A1Kuopio Center for Gene and Cell Therapy Oy
- Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity17 Oct 2019US 2019/0315808 A1Kuopio Center for Gene and Cell Therapy Oy
- Method of producing a polypeptide or v!rus of interest in a continuous cell culture23 May 2019US 2019/0153400 A1Baxalta Incorporated
Most cited
By later US patents